Overview.
Heart disease is the leading cause of death, yet it's largely preventable. Standard cholesterol testing (total cholesterol, LDL-C) misses up to 50% of people who will have heart attacks. Modern cardiovascular risk assessment uses particle counts, inflammatory markers, and genetic risk factors to identify at-risk individuals decades earlier.
Ranked biomarkers.
#1 ApoB (Apolipoprotein B)
Atherosclerosis is caused by atherogenic particles entering artery walls—not cholesterol mass. ApoB counts these particles directly. Two people with identical LDL-C can have vastly different ApoB (and risk).
Optimal range: < 80 mg/dL (high risk: < 60 mg/dL)
Key insight: When LDL-C and ApoB disagree, trust ApoB. Discordance is common with metabolic syndrome, where small dense particles carry less cholesterol each.
#2 Lp(a) (Lipoprotein-a)
Lp(a) is genetically determined and doesn't change with lifestyle. Elevated Lp(a) (>50 nmol/L) increases heart attack risk 2-3x regardless of LDL-C. Yet most people have never been tested.
Optimal range: < 30 nmol/L (< 50 nmol/L acceptable)
Key insight: Test once in your lifetime—it doesn't change. If elevated, you need aggressive LDL-C/ApoB reduction to offset the added risk.
#3 hs-CRP
Inflammation drives plaque instability and rupture—the cause of heart attacks. hs-CRP predicts cardiovascular events independent of cholesterol levels.
Optimal range: < 1.0 mg/L (low risk: < 0.5 mg/L)
Key insight: The JUPITER trial showed that even with normal LDL-C, elevated hs-CRP identifies people who benefit from statins. Inflammation matters.
#4 Triglycerides
High triglycerides indicate metabolic dysfunction and are associated with small dense LDL particles. The triglyceride/HDL ratio predicts insulin resistance and cardiovascular risk.
Optimal range: < 100 mg/dL (fasting)
Key insight: Triglycerides respond dramatically to carbohydrate reduction. Fasting triglycerides under 70 with HDL above 50 indicates excellent metabolic health.
#5 HDL-C (HDL Cholesterol)
HDL performs reverse cholesterol transport—removing cholesterol from arteries. Low HDL is an independent risk factor, especially when triglycerides are high.
Optimal range: > 50 mg/dL (men), > 60 mg/dL (women)
Key insight: The triglyceride/HDL ratio under 2.0 indicates good metabolic health. Exercise, moderate alcohol, and weight loss raise HDL.
#6 LDL-C (LDL Cholesterol)
LDL-C remains important for monitoring, even though ApoB is superior. Most guidelines and drug trials use LDL-C targets.
Optimal range: < 100 mg/dL (high risk: < 70 mg/dL)
Key insight: LDL-C and ApoB usually correlate, but when they don't, ApoB is more predictive. Calculate non-HDL-C (total minus HDL) as a free ApoB proxy.
#7 Homocysteine
Elevated homocysteine damages blood vessel walls, promotes clotting, and accelerates atherosclerosis. It's an independent cardiovascular risk factor.
Optimal range: < 10 μmol/L
Key insight: Often reflects B vitamin deficiency (B12, folate, B6). Easy to treat with methylated B vitamins if elevated.
#8 Fasting Glucose / HbA1c
Diabetes doubles cardiovascular risk. Even prediabetes (glucose 100-125) significantly increases heart disease. Glucose control is cardiovascular prevention.
Optimal range: Fasting glucose < 90 mg/dL, HbA1c < 5.4%
Key insight: Metabolic syndrome (high glucose + triglycerides + low HDL + abdominal obesity + hypertension) is a cardiovascular emergency requiring aggressive intervention.
How to test.
Request an advanced lipid panel: ApoB, Lp(a), lipid panel (LDL-C, HDL-C, triglycerides, total cholesterol), hs-CRP, homocysteine, fasting glucose, and HbA1c. Lp(a) only needs to be tested once. Other markers should be tested annually, or more frequently if optimizing.
FAQs.
Why don't doctors routinely test ApoB and Lp(a)?
Guidelines are slow to change. ApoB and Lp(a) are now recommended by major cardiology societies, but not all practitioners have updated their practice. You can request these tests specifically.
Is total cholesterol still important?
Total cholesterol is largely obsolete for risk assessment. It combines LDL-C (harmful), HDL-C (protective), and VLDL-C. You can have high total cholesterol due to high HDL—which is actually good. Focus on ApoB and LDL-C instead.
What if I have high Lp(a)?
Since Lp(a) is genetic and doesn't respond to lifestyle or current drugs, the strategy is aggressive reduction of other risk factors. Target ApoB under 60 mg/dL. Promising Lp(a)-lowering drugs are in clinical trials.
Can I reverse heart disease with biomarker optimization?
Aggressive lipid lowering (ApoB under 50-60 mg/dL) combined with lifestyle changes has been shown to regress coronary plaque in imaging studies. Early intervention is key—prevention is easier than reversal.
Verdict.
Standard cholesterol testing is incomplete. ApoB counts atherogenic particles, Lp(a) reveals genetic risk, and hs-CRP captures inflammation—all powerful predictors that most people never test. Request these biomarkers to understand your true cardiovascular risk and take targeted preventive action.